Human Genome Sciences

Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences
Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences
Reuters
GSK
M&A
Human Genome Sciences
Flag link:
10 top drug launch disasters
10 top drug launch disasters
Fierce Pharma
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Flag link:
AstraZeneca In Strong Position With Brilinta
AstraZeneca In Strong Position With Brilinta
Seeking Alpha
Brilinta
AstraZeneca
Bristol-Myers Squibb
GSK
Sanofi
Human Genome Sciences
Medicines Company
Flag link:
GlaxoSmithKline: Don't Pass On This Long-Term Gem
GlaxoSmithKline: Don't Pass On This Long-Term Gem
Seeking Alpha
GSK
Abbott Laboratories
Pfizer
Merck
JNJ
Human Genome Sciences
Flag link:
9 Rallying Healthcare Stocks Seeing Strong Sales Trends
9 Rallying Healthcare Stocks Seeing Strong Sales Trends
Seeking Alpha
Cynosure
Human Genome Sciences
Alexion
Watson
The Medicines Company
Gilead Sciences
Medtox
Trinity Biotech
Flag link:
GSK completes $3 billion acquisition of Human Genome
GSK completes $3 billion acquisition of Human Genome
Reuters
GSK
Human Genome Sciences
M&A
Flag link:
Loss at HGSI Wider Than Expected
Loss at HGSI Wider Than Expected
Yahoo/Zacks
earnings
Human Genome Sciences
Flag link:
GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
Seeking Alpha
R&D
GSK
Pfizer
Theravance
Human Genome Sciences
Gilead
Flag link:
A Busy Week For Bio-Pharma Earnings, Drug Approvals
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Flag link:
Dealtalk: Surge in biotech deals to unlock big investor profits
Dealtalk: Surge in biotech deals to unlock big investor profits
Reuters
M&A
GSK
Human Genome Sciences
Flag link:
Human Genome agrees to Glaxo's $3.6B bid
Human Genome agrees to Glaxo's $3.6B bid
Marketwatch
GSK
M&A
Human Genome Sciences
Flag link:
GSK in weekend talks to buy Human Genome: sources
GSK in weekend talks to buy Human Genome: sources
Reuters
GSK
Human Genome Sciences
M&A
Flag link:
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Flag link:
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk
Flag link:
Exclusive: Celgene mulls Human Genome Sciences bid - source
Exclusive: Celgene mulls Human Genome Sciences bid - source
Reuters
Celgene
Human Genome Sciences
M&A
Flag link:
6 Pharmaceutical Stocks To Consider Now
6 Pharmaceutical Stocks To Consider Now
Seeking Alpha
GSK
Human Genome Sciences
Abbott Laboratories
JNJ
Pfizer
Merck
Flag link:
3 Things to Watch With Human Genome Sciences
3 Things to Watch With Human Genome Sciences
Motley Fool
Human Genome Sciences
M&A
Benlysta
Flag link:
GSK again extends its $2.6 billion Human Genome offer
GSK again extends its $2.6 billion Human Genome offer
Reuters
GSK
Human Genome Sciences
M&A
Flag link:
Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Seeking Alpha
M&A
heart disease
Human Genome Sciences
Amylin
GSK
Eli Lilly
Merck
Novo Nordisk
Pfizer
Flag link:
Showdown Looms Between Glaxo and Human Genome Sciences
Showdown Looms Between Glaxo and Human Genome Sciences
WSJ Online
GSK
Human Genome Sciences
M&A
Flag link:

Pages